Ketamine and Esketamine augmentation for suicidal ideation: A randomized, double-blinded clinical trial

Autor:	Flávia Vieira, Manuela Telles, Breno Souza-Marques, Lucas Araújo-de-Freitas, Lucas C. Quarantini, Mariana V.F. Echegaray, Samantha S. Silva, Felipe Coelho Argolo, Roberta Ferrari Marback, Gustavo Turecki, Daniel H Lins-Silva, Flávio Kapczinski, Fernanda S. Correia-Melo, Ana Teresa Caliman-Fontes, Ana Paula Jesus-Nunes, Graziele Beanes, Rodrigo P. Mello, Cassio Santos-Lima, Taiane de Azevedo Cardoso, Acioly L.T. Lacerda, Gustavo C. Leal, Igor D. Bandeira
Rok vydání:	2020
Předmět:	medicine.medical_specialty business.industry Double blinded medicine.disease Antidepressive Agents Suicidal Ideation Clinical trial Psychiatry and Mental health Esketamine Depressive Disorder Treatment-Resistant Internal medicine medicine Humans Ketamine medicine.symptom business Suicidal ideation Treatment-resistant depression Depression (differential diagnoses) medicine.drug
Zdroj:	General hospital psychiatry. 68
ISSN:	1873-7714
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69f69613f459952e96d0f3f2d2097a65 https://pubmed.ncbi.nlm.nih.gov/33376001 Zobrazit plný text záznamu Full Text from ScienceDirect